Metabolic vulnerability in triple-negative breast cancer*cells may help quell chemoth
 

A team of researchers led by Alex Toker of the Ludwig Center at Harvard has discovered a metabolic weakness in triple-negative breast cancer cells that may be exploited to quell their resistance to chemotherapy.

More...